H2QFB9 (H2QFB9_PANTR) Pan troglodytes (Chimpanzee)

Kelch-like ECH-associated protein 1 UniProtKBInterProSTRINGInteractive Modelling

624 aa; Sequence (Fasta) ; 4 identical sequences: Homo sapiens: Q14145; Pan troglodytes: A0A6D2X5C6; Pan paniscus: A0A2R9BRR8; Gorilla gorilla gorilla: G3QHR9

Available Structures

103 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Kelch domain of human KEAP1 bound to Nrf2 peptide, ADEETGEFA Heteromer
Q14145; Q16236;
327-612
99.3
Crystal Structure of the Kelch-Neh2 Complex Heteromer
Q14145; Q16236;
325-609
100
Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexes Heteromer
Q14145; Q16236;
325-609
100
De novo design and crystallographic validation of antibodies targeting a pre-selected epitope Heteromer
Q14145;
325-609
99.65
crystal structure of the KEAP1-NEH2 complex Heteromer
Q14145; Q16236;
325-609
99.3ACT;
KEAP1 IN COMPLEX WITH PEPTIDE 8 Heteromer
Q14145; Q16236;
325-609
99.3ACT;
Kelch domain of human Keap1 bound to Nrf2 ETGE peptide Heteromer
Q14145; Q16236;
326-609
99.3
Kelch domain of human KEAP1 bound to Nrf2 peptide, ADEETGEFL Heteromer
Q14145; Q16236;
326-609
99.3
Kelch domain of human KEAP1 bound to Nrf2 peptide, LDEETGEFA Heteromer
Q14145; Q16236;
327-609
99.29
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[BAL-DEETGE] Heteromer
Q14145; Q16236;
327-609
99.29
Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-GDPETGE-NH2 Heteromer
Q14145; Q16236;
327-609
99.29
Kelch domain of human KEAP1 bound to Nrf2 peptide, ADEETGEAA Heteromer
Q14145; Q16236;
327-609
99.29SO4;
Kelch domain of human KEAP1 bound to Nrf2 peptide, LDEETGEAL Heteromer
Q14145; Q16236;
327-609
99.29SO4;
Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-(BAla)DPETGE-NH2 Heteromer
Q14145; Q16236;
327-609
99.29
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[GDEETGE] Heteromer
Q14145; Q16236;
328-609
99.29
Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-GDEETGE-NH2 Heteromer
Q14145; Q16236;
330-609
100
Crystal structure of human CUL3 N-terminal domain bound to KEAP1 BTB and 3-box Heteromer
Q13618; Q14145;
51-204
100
The structure of the F64A, S172A mutant Keap1-BTB domain in complex with SKP1-FBXL17 Heteromer
P63208; Q14145; Q9UF56;
50-179
98.46
Structure of a substrate-bound DQC ubiquitin ligase Heteromer
P63208; Q13616; Q14145; Q9UF56;
50-179
99.23
STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S,2R)-2-[(1S)-1-[(1-oxo-2,3-dihydro-1H-isoindol-2-Yl)methyl]-…homo-3-mer325-611
99.32FS;ACT;
Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-5-methyl-1-[(1-oxo-1,3-dihydro-2H-isoindol-2-…homo-3-mer325-609
99.651VX; 10×ACT;
Structure of keap1 kelch domain with 2-{[(1S)-2-{[(1R,2S)-2-(1H-tetrazol-5-yl)cyclohexyl]carbonyl}-…homo-3-mer326-609
99.651VW;ACT;
Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-1-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)me…homo-2-mer321-609
99.65ACT;1VV;NA;
Crystal Structure of the KELCH domain of human KEAP1homo-2-mer324-609
100FMT;NA;
Human Kelch like-ECH Associated Protein 1 (Keap1)homo-2-mer324-609
100
crystal structure of a KEAP1 mutanthomo-2-mer325-609
99.310×ACT;NA;
Keap1 - peptide complexhomo-2-mer325-609
100EDO;ACT;NA;
Keap1 - peptide complexhomo-2-mer325-609
10010×ACT;EDO;CL;NA;
Low resolution crystal structure of Keap1-456, a repeat fragment from the human Keap1 beta-propellerhomo-2-mer471-609
100.0
BTB domain of KEAP1 in complex with CDDOhomo-2-mer49-180
99.24SXJ;
KEAP1 BTB domain in complex with the covalent activator VVD-065homo-2-mer48-178
99.19A1BCT;
Crystal Structure of Human KEAP1 BTB Domain in Complex with isoxazoline-based inhibitorhomo-2-mer50-180
99.24D8N;
The Crystal Structure of KEAP1 from Biortus.homo-2-mer49-179
99.2
BTB domain of KEAP1 C151W mutanthomo-2-mer49-179
98.47
Crystal structure of the BTB domain human Keap1homo-2-mer50-179
99.23
Crystal Structure of Human KEAP1 BTB Domain in Complex with Small Molecule TX64014homo-2-mer50-179
100.0TX6;
Crystal structure of Keap1 BTB domain in complex with dimethyl fumarate (DMF)homo-2-mer50-179
99.219HB;
The structure of S172A Keap1-BTB domainhomo-2-mer51-179
99.22
The structure of F64, S172A Keap1-BTB domainhomo-2-mer51-179
98.45
The structure of V98A S172A Keap1-BTB domainhomo-2-mer51-179
98.45
BTB domain of KEAP1 in complex with MEFhomo-2-mer50-178
99.229J3;
Crystal Structure of Human KEAP1 BTB Domain in Complex with Small Molecule TX64063homo-2-mer50-177
100.058E;
Crystal structure of Keap1 in complex with dimethyl fumarate (DMF)monomer319-613
95.25EOU;ACT;PG5;SO4;
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interacti…monomer321-613
100A1LVC;ACT;SO4;
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1/Nrf2 PPI Inhibitor for Treatment of …monomer321-613
100T6I;SO4;
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1/Nrf2 PPI Inhibitor for Treatment of …monomer321-613
100SIU;SO4;
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1/Nrf2 PPI Inhibitor for Treatment of …monomer321-613
100SGO;DTT;SO4;
Kelch domain of KEAP1 in complex with a ortho-dimethylbenzene linked cyclic peptide 5 (ortho-WRCDPE…monomer324-615
98.97SO4;CL;EDO;GOL;NA;
Kelch domain of KEAP1 in complex with a ortho-dimethylbenzene linked cyclic peptide 4 (ortho-WRCDEE…monomer324-615
98.97SO4;CL;EDO;GOL;NA;
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interacti…monomer322-612
100A1LVB;ACT;SO4;
Kelch domain of KEAP1 in complex with a ortho-dimethylbenzene linked cyclic peptide 11 (ortho-WRCNP…monomer324-614
98.97CL;EDO;GOL;NA;
Kelch domain of KEAP1 in complex with ortho-dimethylbenzene linked cyclic peptide 3 (ortho-WRCDEETG…monomer325-614
98.97SO4;CL;GOL;EDO;
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[BAL-NPETGE]monomer326-614
98.96
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GEPETGE]monomer326-614
98.96
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[LhA-DEETGE]monomer326-614
98.96
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[DhA-GDPETGE]monomer326-614
98.96
Kelch domain of human Keap1 bound to small molecule inhibitor fragment: 4-oxo-4H-1-benzopyran-2-car…monomer325-613
98.96SO4;
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[DhA-GDPET(bAla)E]monomer326-614
98.96
1.35 angstrom structure of the Kelch domain of Keap1monomer322-609
99.65
Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexesmonomer322-609
100
Crystal structure of the Kelch domain of human Keap1monomer322-609
100
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GDPETGE]monomer327-614
99.65
Crystal Structure of Keap1 Soaked with Synthetic Small Molecularmonomer322-609
100FUU;
Crystal Structure of Keap1 in Complex with Synthetic Small Molecular based on a co-crystallizationmonomer322-609
100FUU;
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GDEEAGE]monomer327-614
98.96
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[Ahx-DPETGE]monomer327-614
98.96
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GDPEAGE]monomer327-614
98.96
Crystal structure of cpd 15 bound to Keap1 Kelch domainmonomer322-609
100PO4;4ID;
Crystal structure of the Kelch domain in complex with 11 amino acid peptide (model of the ETGE loop)monomer322-609
100NA;
Crystal structure of Keap1 Kelch domain (residues 322-609) in complex with 6kmonomer323-609
100.0GED;
Crystal structure of N-(4-((4-methoxy-N-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-…monomer324-609
99.3Q5V;FMT;DMS;NA;
Keap1 Kelch domain (residues 322-609) in complex with 6imonomer324-609
100.0GCI;
Crystal structure of 2,2'-(naphthalene-1,4-diylbis(((4-methoxyphenyl)sulfonyl)azanediyl))diacetamid…monomer324-609
10041P;
KEAP1 Kelch domain in complex with Compound 9monomer325-609
100GOL;DMS;08A;
Crystal structure of N-[(4-methoxyphenyl)sulfonyl]-N-(4-{[(4-methoxyphenyl)sulfonyl]amino}naphthale…monomer325-609
99.311×FMT;Q5Y;NA;
Keap1 - inhibitor complexmonomer325-609
100EDO;GX8;NA;
Crystal structure of cpd 16 bound to Keap1 Kelch domainmonomer325-609
98.95IQK;
Keap1 compound complexmonomer325-609
99.391M;CL;
Keap1 compound complexmonomer325-609
99.39IB;CL;
Crystal structure of Keap1 Kelch domain (residues 322-609) in complex with NXPZ-2monomer325-609
100.0GFD;
Crystal structure of the Keap1 Kelch domain in complex with a tetrapeptidemonomer325-609
100
Keap1 compound complexmonomer325-609
99.392I;CL;
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GAEETGE]monomer325-609
100
Keap1 macrocycle complexmonomer325-609
99.3Q9E;NA;CL;
Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexesmonomer325-609
10012O;
Keap1 compound complexmonomer325-609
99.39P0;CL;
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GAPETGE]monomer325-609
100
Keap1 compound complexmonomer325-609
99.38ZL;NA;CL;
KEAP1 IN COMPLEX WITH COMPOUND 6monomer325-609
99.3LQ8;ACT;
Crystal structure of Keap1 Kelch domain (residues 322-609) in complex with 6emonomer325-609
100.0GDJ;
Crystal structure of Keap1_6kmonomer325-609
100.0HB6;
KEAP1 IN COMPLEX WITH COMPOUND 44monomer326-609
99.3ACT;
Kelch domain of human Keap1 bound to small molecule inhibitor fragment: 4-amino-1,7-dihydro-6H-pyra…monomer326-609
99.3SO4;1XM;
KEAP1 Kelch domain in complex with Compound 2monomer326-609
100FMT;PKG;
KEAP1 IN COMPLEX WITH COMPOUND 23monomer326-609
99.3LQK;
Kelch domain of human Keap1 in open unliganded conformationmonomer327-609
99.29SO4;
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[GABA-DPETGE]monomer327-609
100
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[AVA-DPETGE]monomer327-609
100
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[BAL-DEETGE]monomer327-609
100SO4;
Kelch domain of human Keap1 bound to mutant Nrf2 EAGE peptidemonomer330-609
99.29SO4;
Kelch domain of human Keap1 bound to inhibitory small molecule fragment: hydroxyphenyl propionic ac…monomer330-609
99.29HPP;
BTB domain of KEAP1 in complex with XX3monomer51-180
99.23XXT;
BTB domain of KEAP1monomer50-179
99.23

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2dyh.1.Amonomer0.91324-619
96.21
6wcq.1.Cmonomer0.7550-179
99.84